As 2022 drew to a close, US President Joe Biden quietly signed a law that rewarded countless researchers and animal-rights activists with a long-sought goal – ending a decades-old requirement that all new drugs must be tested in animals before running studies in humans.
As a result, drug developers can now submit various alternatives based on a growing menu of new technologies, including cell-based...
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on In Vivo for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?